J&J is seeding small, high-risk ventures through RedScript Ventures, a two-year-old accelerator program.
A huge health-care company like Johnson & Johnson requires a steady stream of innovation, but that’s getting harder and harder to create. So the 125-year-old company is getting more aggressive at mining ideas from outside. It’s seeking out very early ventures that it once would have considered far too risky and seeding them with money or dishing out advice on how to nudge untested ideas out of the laboratory.
Some experts say J&J’s relationship to innovation is the right model for a large company. “It lets the marketplace do what it does best, which is have an explosion of different kinds of companies in various fields,” says Richard Foster, lead director of the board at Innosight, a consulting firm that has done work for J&J. “These companies will need major infusions of capital, or a global distribution chain. At that point, J&J says, ‘We are very effective in rolling innovations out—very quickly and cost efficiently [Source].’”




Recent Comments